Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Evoke Pharma Inc. (EVOK)

3.64   0.03 (0.83%) 07-07 15:43
Open: 3.59 Pre. Close: 3.61
High: 3.64 Low: 3.46
Volume: 406,254 Market Cap: 90M
Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray, which is completed Phase III clinical trials for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. The company was founded in 2007 and is headquartered in Solana Beach, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.792 - 3.812 3.812 - 3.826
Low: 3.467 - 3.487 3.487 - 3.501
Close: 3.579 - 3.612 3.612 - 3.637

Technical analysis

as of: 2020-07-07 3:04:17 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 5.84     One year: 6.82
Support: Support1: 3.21    Support2: 2.10
Resistance: Resistance1: 5.00    Resistance2: 5.84
Pivot: 3.28
Moving Average: MA(5): 3.60     MA(20): 3.06
MA(100): 1.76     MA(250): 1.40
MACD: MACD(12,26): 0.40     Signal(9): 0.39
Stochastic oscillator: %K(14,3): 51.19     %D(3): 51.58
RSI: RSI(14): 64.75
52-week: High: 5.00  Low: 0.73  Change(%): 308.0
Average Vol(K): 3-Month: 157009  10-Days: 158807

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
EVOK has closed below upper band by 36.7%. Bollinger Bands are 194.3% wider than normal. The large width of the bands suggest high volatility as compared to EVOK's normal range. The bands have been in this wide range for 10 bars. This is a sign that the current trend might continue.

Headline News

Fri, 26 Jun 2020
Wall Street's Thoughts on Evoke Pharma Inc (EVOK) Stock - InvestorsObserver

Thu, 25 Jun 2020
Is Evoke Pharma Inc (EVOK) Stock a Good Value Thursday? - InvestorsObserver

Thu, 25 Jun 2020
Evoke Pharma Inc (NASDAQ:EVOK) Hits New High After the FDA Approval - Small Cap Exclusive

Tue, 23 Jun 2020
Evoke Pharma Inc. (NASDAQ:EVOK) Recent Earnings Shows Major Promise - The Oracle Dispatch

Tue, 23 Jun 2020
Evoke Pharma, Inc. (EVOK) Gains 512.90% in one Year: What’s Next? - The News Heater

Mon, 22 Jun 2020
Evoke Pharma +71% PM on FDA approval - Seeking Alpha

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Drug ManufacturersSpecialty & Generic
Shares Out. (M) 25
Shares Float (M) 22
% Held by Insiders 4.15
% Held by Institutions 14.52
Shares Short (K) 310
Shares Short P. Month (K) 123

Stock Financials

EPS -0.289
EPS Est This Year -0.820
EPS Est Next Year -0.170
Book Value (p.s.) 0.120
Profit Margin
Operating Margin
Return on Assets (ttm) -96.9
Return on Equity (ttm) -231.8
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -5
Levered Free Cash Flow (M) -3

Stock Valuations

PE Ratio -12.35
PEG Ratio
Price to Book value 29.75
Price to Sales
Price to Cash Flow -16.36

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.